Dr Jason Loveridge –
Non Executive Chairman
Dr Loveridge is a founder of Invex Therapeutics and currently CEO of 4SC AG, a German listed oncology company. He has more than thirty years’ of international experience across Europe, Asia and the US in senior management positions in life sciences companies and as an investment professional dealing in both privately held and publicly traded companies. Additionally, he has substantial transactional experience in the sale and partnering of biotechnology assets. Dr Loveridge graduated in Biochemistry and Microbiology from the University of New South Wales, Australia, and holds a Ph.D. in Biochemistry from the University of Adelaide, Australia. He is also a fellow of the Royal Society of Medicine.